{
    "2018-10-16": [
        [
            {
                "time": "",
                "original_text": "[增持评级]医药生物行业周报：17种抗癌药纳入医保目录 创新药研发长期享受政策红利",
                "features": {
                    "keywords": [
                        "医药生物",
                        "抗癌药",
                        "医保目录",
                        "创新药",
                        "政策红利"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}